SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0000897101-23-000083
Filing Date
2023-02-14
Accepted
2023-02-14 14:45:11
Documents
1

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 6 TO SCHEDULE 13G cullen230187_13ga.htm SC 13G/A 48579
  Complete submission text file 0000897101-23-000083.txt   50073
Mailing Address 712 VISTA BLVD #305 WACONIA MN 55387
Business Address 712 VISTA BLVD #305 WACONIA MN 55387 9524791196
Panbela Therapeutics, Inc. (Subject) CIK: 0001029125 (see all company filings)

IRS No.: 870543922 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-88985 | Film No.: 23627427
SIC: 2834 Pharmaceutical Preparations

Mailing Address 712 VISTA BLVD, #305 WACONIA MN 55387
Business Address
Cullen Michael T. (Filed by) CIK: 0001652996 (see all company filings)

Type: SC 13G/A